Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/26/1998WO1998052577A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998WO1998052576A1 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
11/26/1998WO1998052575A1 Use of metalloproteinase inhibitors in the treatment and prevention of pulmonary emphysema
11/26/1998WO1998052574A1 Vitamin d analogues and their neuronal effects
11/26/1998WO1998052573A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/26/1998WO1998052572A1 Use of taurolidine for treatment of leukemias
11/26/1998WO1998052571A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998WO1998052570A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998WO1998052569A1 Combination therapy for modulating the human sexual response
11/26/1998WO1998052568A1 THE USE OF 1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
11/26/1998WO1998052567A1 Method for treating headache pain with topical local anesthetic compositions
11/26/1998WO1998052566A1 Non-sedating acrivastine preparation
11/26/1998WO1998052565A1 Substance dependence treatment using opiate antagonists and serotonin compounds
11/26/1998WO1998052564A1 Benzimidazole pharmaceutical composition and process of preparation
11/26/1998WO1998052563A1 REMEDIES FOR DEMENTIA OF ALZHEIMER TYPE CONTAINING η-SULTAM DERIVATIVES
11/26/1998WO1998052562A1 Pharmaceutical composition containing uscharidin or its analogues
11/26/1998WO1998052561A1 Carotenoid formulation
11/26/1998WO1998052560A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/26/1998WO1998052559A1 Raf kinase inhibitors
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998052557A1 2,3-dihydrobenzofuran derivatives
11/26/1998WO1998052556A1 Glucosamine fatty acid compositions and their use
11/26/1998WO1998052555A2 Use of n-acetyl-l-cysteine for treating male infertility
11/26/1998WO1998052553A1 Methods for treatment of conditions associated with lactosylceramide
11/26/1998WO1998052550A1 Pharmaceutical composition and use thereof
11/26/1998WO1998052548A2 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
11/26/1998WO1998052547A1 Gastroretentive controlled release microspheres for improved drug delivery
11/26/1998WO1998052546A1 Use of isoflavonoids in the treatment or prevention of postpartum depression
11/26/1998WO1998052544A1 Composition comprising finely divided, crystalline particles of budesonide
11/26/1998WO1998052542A1 Medicinal aerosol products
11/26/1998WO1998052540A1 Pharmaceutical compositions
11/26/1998WO1998052539A1 Process for making flurbiprofen lozenges
11/26/1998WO1998052518A1 Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
11/26/1998WO1998052515A1 Prevention/retardation of hair growth
11/26/1998WO1998052514A2 Treatment of hepatic cirrhosis
11/26/1998WO1998052415A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998WO1998040357A3 Hiv protease inhibitors
11/26/1998WO1998036776A3 Gel delivery vehicles for anticellular proliferative agents
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/26/1998WO1998035655A3 Method for separating active substances in solid pharmaceutical preparations
11/26/1998WO1998035554A3 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/26/1998WO1998022494A3 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS
11/26/1998WO1998020834A3 Method for treatment of dermatological disorders
11/26/1998DE19750422C1 Use of esters of phyto-sterols
11/26/1998DE19739332C1 New 5-Ý4-(4-fluorobenzyl)-piperidin-1-yl¨-3(4-hydroxyphenyl)-oxazolidine-2-one
11/26/1998DE19722848A1 Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular oximo-LTB¶4¶ antagonists
11/26/1998DE19721580A1 Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension states
11/26/1998DE19721099A1 Verwendung von Fumarsäurederivaten Use of fumaric acid derivatives
11/26/1998CA2294804A1 Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
11/26/1998CA2291169A1 Metalloproteinase inhibitors
11/26/1998CA2291156A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998CA2291132A1 Pharmaceutical composition containing uscharidin or its analogues
11/26/1998CA2291123A1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2291112A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998CA2291111A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998CA2290831A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998CA2290824A1 Benzimidazole pharmaceutical composition and process of preparation
11/26/1998CA2290818A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998CA2290789A1 Analogs of duocarmycin and cc-1065
11/26/1998CA2290788A1 Substance dependence treatment using opiate antagonists and serotonin compounds
11/26/1998CA2290772A1 Vitamin d analogues and their neuronal effects
11/26/1998CA2290602A1 88kda tumorigenic growth factor and antagonists
11/26/1998CA2290598A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998CA2290556A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998CA2290546A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998CA2290488A1 Glucosamine fatty acid compositions and their use
11/26/1998CA2290475A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998CA2290461A1 Antiseptic composition
11/26/1998CA2290459A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998CA2290458A1 Use of isoflavonoids in the treatment or prevention of postpartum depression
11/26/1998CA2290426A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998CA2290381A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/26/1998CA2290040A1 Smad7 and uses thereof
11/26/1998CA2289945A1 Human uncoupling protein 3
11/26/1998CA2289847A1 The use of 1,2,4-triazolo¬1,5-c|pyrimidine heterocyclic analogues for the preparation of medicaments useful for the treatment of cerebrovascular disturbances
11/26/1998CA2289675A1 20-aralkyl-5.alpha.-pregnane derivatives
11/26/1998CA2289655A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2289654A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2289605A1 Cis-substituted substituted aminocycloalkylpyrrolidine derivatives
11/26/1998CA2289594A1 Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2288629A1 Cyclohexanediol derivatives
11/26/1998CA2288327A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998CA2287977A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998CA2287484A1 Compounds for inhibition of ceramide-mediated signal transduction
11/26/1998CA2285580A1 Gastroretentive controlled release microspheres for improved drug delivery
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998EP0879881A1 A human gene similar to a secreted protein frizb (ATG-1639)
11/25/1998EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998EP0879824A1 Triterpene derivatives and remedy for liver diseases
11/25/1998EP0879823A1 Preparation of azithromycin
11/25/1998EP0879820A1 Benzamide analogues, useful as PARP (ADP-Ribosyltransferase, ADPRT) DNA repair enzyme inhibitors
11/25/1998EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998EP0879605A2 Glycosyl prodrug conjugate with enhanced tolerance
11/25/1998EP0879604A1 Konjugate comprising a Folic acid antagonist and a carrier
11/25/1998EP0879601A2 Ophthalmic drug delivery system
1 ... 6575 6576 6577 6578 6579 6580 6581 6582 6583 6584 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 6595 ... 7860